To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

The purpose of this study is to assess the pharmacokinetics (ie, how the body affects the drug) and safety of JNJ-54452840 in healthy participants.

Key facts

Study ID

NCT01809353

Run by

Janssen Research & Development, LLC

People needed

32

Starts

2013-07-01

Expected to finish

2014-09-01

Last updated by the study team

2015-03-23

Who can join

Age: 20 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Must be a healthy male with no clinically relevant abnormalities as determined by medical history, physical examination, blood chemistry assessments, hematologic assessments - Must be Japanese or Caucasian
• Japanese participants must have been born in Japan, have resided outside of Japan for no more than 5 years, and have Japanese parents and maternal and paternal grandparents
• Caucasian participants must have Caucasian parents

You may not qualify if…

• History of or current clinically significant medical illness that the investigator considers should exclude the participant or that could interfere with the interpretation of the study results
• Have a known or suspected intolerance or hypersensitivity to any biologic medication or known allergies or clinically significant reactions to murine, chimeric, or human peptides or protein
• Be unable or unwilling to undergo multiple venipunctures because of poor tolerability or lack of easy access to veins

Where it is running

• Study site — Cypress, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.